Author:
Yanovich S,Mitsky P,Cornetta K,Maziarz RT,Rosenfeld C,Krause DS,Lotz J-P,Bitran JD,Williams S,Preti R,Somlo G,Burtness B,Mills B
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference38 articles.
1. Bearman SI, Shpall EJ, Jones RB et al. High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer Semin Oncol 1996 23: 60–67
2. Antman KH, Rowlings PA, Vaughan WP et al. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America J Clin Oncol 1997 15: 1870–1879
3. Hortobagyi GN, Buzdar AU, Champlin R et al. Lack of efficacy of adjuvant high-dose (HD) tandem combination chemotherapy (CT) for high-risk primary breast cancer (HRPBC)-a randomized trial Proc Am Soc Clin Oncol 1998 17: 12
4. Rodenhuis S, Richel DJ, van der Wall E et al. Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement Lancet 1998 352: 515–521
5. Bergh J, . ScandinavianBreastCancerStudyGroup9401 Results from a randomized adjuvant breast cancer study with high dose chemotherapy with CTCb supported by autologous bone marrow stem cells versus dose escalated and tailored FEC therapy Proc Am Soc Clin Oncol 1999 18: 2A
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献